论文部分内容阅读
目的:提高中药注射剂的用药安全性。方法:采用前瞻性多中心随机对照法,选取天津市第一中心医院和天津中医药大学第一附属医院2006年10月～2007年5月的住院病例为研究对象,随机分为对照组和干预组,采用宣传教育、行政干预、监督检查等干预措施,针对适应证因素对中药注射剂应用进行干预,并观察不良反应发生率的变化对干预组与对照组的结果进行分析研究。结果:与对照组比较,干预组中药注射剂使用的适应证更加合理(P<0.05),不良反应的发生率显著降低(P<0.01),临床疗效也显著提高(P<0.01),平均住院费用有所下降。结论:适应证干预后不良反应发生率大大降低,干预有效。
Objective: To improve the safety of traditional Chinese medicine injections. METHODS: A prospective multicenter randomized controlled trial was used to select hospitalized cases from October 2006 to May 2007 in the First Central Hospital of Tianjin and the First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. The subjects were randomly divided into control groups and interventions. The group adopted interventions such as publicity and education, administrative interventions, and supervision and inspections to intervene in the use of TCM injections for indication factors, and observed changes in the incidence of adverse reactions to analyze the results of the intervention group and the control group. Results: Compared with the control group, the indications for TCM injections in the intervention group were more reasonable (P<0.05), the incidence of adverse reactions was significantly lower (P<0.01), the clinical curative effect was also significantly improved (P<0.01), and the average hospital cost Declined. Conclusion: The incidence of adverse reactions after the indication intervention is greatly reduced and the intervention is effective.